Upgrade to SI Premium - Free Trial

Target (TGT) PT Raised to $153 at Roth/MKM, 'Physical Comp Sales Continue to Slide'

March 6, 2024 4:06 AM
Roth/MKM analyst Bill Kirk raised the price target on Target (NYSE: TGT) to $153.00 (from $140.00) while maintaining a Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles